Regeneron Pharmaceuticals, Inc.

DEUTSCHE BANK AG\ REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

763,926

Value ($000)

589,652

Weight

0.2%

2013 Q4 - 2025 Q4 (29 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	589,652	0.2%	763,926	12/31/2025
2025 Q3	11/13/2025	391,723	0.1%	696,681	9/30/2025
2025 Q2	8/12/2025	373,189	0.1%	710,837	6/30/2025
2025 Q1	5/9/2025	344,445	0.1%	543,092	3/31/2025
2024 Q4	6/30/2025	384,137	0.2%	539,269	12/31/2024
2024 Q3	6/26/2025	465,636	0.2%	442,940	9/30/2024
2024 Q2	6/12/2025	421,644	0.2%	401,172	6/30/2024
2024 Q1	6/2/2025	300,370	0.1%	312,076	3/31/2024
2023 Q4	2/14/2024	285,791	0.1%	325,395	12/31/2023
2023 Q3	11/24/2023	223,541	0.1%	271,631	9/30/2023
2023 Q2	8/14/2023	215,405	0.1%	299,781	6/30/2023
2023 Q1	5/15/2023	248,762	0.1%	302,752	3/31/2023
2022 Q4	2/13/2023	233,790	0.1%	324,038	12/31/2022
2022 Q3	11/14/2022	224,056	0.1%	325,254	9/30/2022
2022 Q2	8/11/2022	214,476	0.1%	362,824	6/30/2022
2022 Q1	5/13/2022	287,754	0.1%	412,005	3/31/2022
2021 Q4	2/16/2022	262,045	0.1%	414,941	12/31/2021
2021 Q3	11/4/2021	271,700	0.1%	448,958	9/30/2021
2021 Q2	8/11/2021	280,225	0.1%	501,711	6/30/2021
2021 Q1	5/13/2021	219,660	0.1%	464,262	3/31/2021
2020 Q4	2/16/2021	207,626	0.1%	429,771	12/31/2020
2020 Q3	11/12/2020	210,956	0.1%	376,857	9/30/2020
2020 Q2	8/13/2020	225,461	0.2%	361,521	6/30/2020
2020 Q1	5/14/2020	191,077	0.2%	391,318	3/31/2020
2019 Q4	2/14/2020	177,841	0.1%	473,647	12/31/2019
2018 Q3	12/21/2021	195,269	—	483,288	9/30/2018
2018 Q2	4/21/2020	273,216	—	791,954	6/30/2018
2014 Q1	5/15/2014	253,684	0.2%	844,835	3/31/2014
2013 Q4	2/24/2014	256,625	0.2%	932,386	12/31/2013